Company: JUNS
Filing Date: 2025-08-19
Form Type: 10-Q
Source: 0001641172-25-024684
Chunk: 11

Company: JUPITER NEUROSCIENCES, INC.
Filing Date: 2025-08-19
Form: 10-Q
Item: Item 8
Chunk 11
---
, 2025 and 2024 were as follows:

Schedule
of Grant Date Fair Value of Stock Options Issued

    June 30,  
    June 30, 

    2025  
    2024 
  
    Dividend Yield 
     0% 
     0
    %
  
    Weighted average expected term (years) 
     5.38  
     5.75-6

    Volatility 
     101.98% 
     97.3-105.8
    %
  
    Risk-free rate 
     4.18% 
     4.10
    %
  
    Weighted average exercise price 
    $0.97  
    $1.33

    17

JUPITER
NEUROSCIENCES, INC.

NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

JUNE
30, 2025

Note
6 – Stockholders’ Equity, continued

A
summary of stock option activity for the six months ended June 30, 2025 is presented below:

Schedule
of Stock Option Activity

    Number of Options  
    Weighted Average Exercise Price  
    Weighted Average Contractual Term (Years)  
    Aggregate Intrinsic Value 
  
    Outstanding as of December 31, 2024 
     10,633,988  
     1.02  
     6.25  
    $102,921,147 
  
    Granted 
     250,000  
     0.97  

    Exercised 
     -  
     -  

    Forfeited 
     -  
     -  

    Outstanding as of June 30, 2025 
     10,883,988  
    $1.02  
     5.61  
    $1,772,167 
  
    Exercisable as of June 30, 2025 
     10,426,478  
    $1.01  
     5.48  
    $1,762,791 

The
following table summarizes information related to stock options outstanding as of June 30, 2025:

Schedule
of Employee Stock Options Outstanding

     Outstanding Options  
     Vested
                                            Options 
  
     Exercise Price  
     Number